InvestorsHub Logo
Followers 29
Posts 2801
Boards Moderated 0
Alias Born 12/05/2021

Re: None

Thursday, 03/07/2024 10:44:28 AM

Thursday, March 07, 2024 10:44:28 AM

Post# of 693898
I have been criticized scolded laughed at many times here, when I repeatedly said that NWBO is not capable of selling DCVAXL. Also, I said that selling and marketing DCVAXL will cost a vast amount of money. The nwbo zealots told me that DCVAXL would sell itself and there was no need for any sales or marketing. From the last 10K:

“Our product candidates will require different marketing and sales methods and personnel than conventional therapeutic products. Also, we lack sales and marketing experience. These factors may result in significant difficulties in commercializing our product candidates.
The commercial success of any of our product candidates will depend upon the strength of our sales and marketing efforts. We do not have a marketing or sales force and have no experience in marketing or sales of products like our lead product, DCVax-L for GBM, or our additional product, DCVax-Direct. To fully commercialize our product candidates, we will need to recruit and train marketing staff and a sales force with technical expertise and ability to manage the distribution of our DCVax-L for GBM. As an alternative, we could seek assistance from a corporate partner or a third-party services firm with a large distribution system and a large direct sales force. However, since our DCVax products are living cell, immune therapy products, and these are a fundamentally new and different type of product than are on the market today, we would still have to train such partner’s or such services firm’s personnel about our products and would have to make changes in their distribution processes and systems to handle our products. We may be unable to recruit and train effective sales and marketing forces or our own, or of a partner or a services firm, and/or doing so may be more costly and difficult than anticipated. Such factors may result in significant difficulties in commercializing our product candidates, and we may be unable to generate significant revenues.



And ofcourse I was right

NWBO will be bought after UK approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News